MedPath

Randomized phase II study of TJ-17 and TJ-114 in patients with lower limb lymphedema after lymphadenectomy for gynecologic malignancy

Not Applicable
Conditions
Secondary lower limb lymphedema
Registration Number
JPRN-UMIN000033605
Lead Sponsor
agoya University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

women were excluded if they 1) were allergy for TJ-17 or TJ-114 2) had other medical severe conditions (i.e., congestive heart failure, chronic/acute renal disease,nephrotic syndrome, nephrosis, liver failure, or severe psychatric disease) 3) were unable to eat 4) were diagnosed as primary lymphedema 5) were suffered from lower limb vein thrombosis 6) were not suitable for participation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
limb circumference
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath